Symbol="GNLX"
AssetType="Common Stock"
Name="Genelux Corporation Common Stock"
Description="Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The company is headquartered in Westlake Village, California."
CIK="1231457"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, UNITED STATES"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="630110000"
EBITDA="-5460000"
PERatio="None"
PEGRatio="None"
BookValue="-4.119"
DividendPerShare="0"
DividendYield="0"
EPS="-0.45"
RevenuePerShareTTM="1.214"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.303"
ReturnOnEquityTTM="0"
RevenueTTM="11238000"
GrossProfitTTM="11068000"
DilutedEPSTTM="-0.45"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="31.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="None"
num_52WeekHigh="40.98"
num_52WeekLow="5.35"
num_50DayMovingAverage="28.62"
num_200DayMovingAverage="23.83"
SharesOutstanding="25983900"
DividendDate="None"
ExDividendDate="None"
symbol="GNLX"
open="23.62"
high="25.53"
low="22.98"
price="24.25"
volume="91374.00"
latest_trading_day="2023-08-15"
previous_close="22.87"
change="1.38"
change_percent="6.0341%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="23"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="56"
Volume_recent_avg="50524"
Change_recent_avg="-0.27"
Delta_recent_avg="2.73"
Variance_recent_avg="1.37"
Change_ratio_recent_avg="-1.16"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="56"
Aroon_momentum_negative="23"
image_negative_thumbnail_id_1="150"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0026.jpeg"
image_negative_thumbnail_id_2="515"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0090.jpeg"
image_neutral_thumbnail_id_1="525"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_neutral_thumbnail_id_2="555"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_positive_thumbnail_id_1="991"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_positive_thumbnail_id_2="992"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0154.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
